# Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

> **NCT00953745** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 43 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Aripiprazole
- **DRUG:** Placebo Capsule
- **DRUG:** Placebo Tablet

## Key facts

- **NCT ID:** NCT00953745
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953745, "Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00953745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*